Fibrinogen Aalpha312 and Bbeta448 polymorphisms are not related to bleeding during oral vitamin K-antagonist treatment.

Garcia, Andrea A; van der Hoeven, Niels V; Boellaard, Thierry N; van der Heijden, Jeroen F; Groot, Angelique P A; Reitsma, Pieter H

Garcia, Andrea A; van der Hoeven, Niels V; Boellaard, Thierry N; van der Heijden, Jeroen F; Groot, Angelique P A; Reitsma, Pieter H.

Thromb Haemost ; 97(4): 676-8, 2007 Apr.

Article in En | MEDLINE | ID: mdl-17393034

Subject(s)

Anticoagulants/adverse effects; Fibrinogen/genetics; Hemorrhage/chemically induced; Polymorphism, Single Nucleotide; Vitamin K/antagonists & inhibitors; Acenocoumarol/adverse effects; Administration, Oral; Anticoagulants/administration & dosage; Case-Control Studies; Genotype; Hemorrhage/genetics; Humans; Netherlands; Odds Ratio; Phenprocoumon/adverse effects; Risk Assessment; Risk Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vitamin K / Fibrinogen / Polymorphism, Single Nucleotide / Hemorrhage / Anticoagulants Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Thromb Haemost Year: 2007 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links